This strategy seems to be particularly relevant in the ALK+ ALCL subtype, whereby the increased expression of PIM2 is associated with shorter survival and the combinatory inhibition of ALK and all PIM kinases potently enhanced apoptosis. Here, PIM2 is linked to anaplastic large cell lymphoma.